The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Entertainment
  • Education
  • Legal
  • Construction
  • Non-profit

Actuated Medical Expands Expertise in Forensic DNA Analysis with Acquisition of Mitotyping Technologies LLC
The PennZone/10253749

Trending...
  • INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
  • Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
Mitotyping Technologies LLC
BELLEFONTE, Pa. - PennZone -- Actuated Medical, a leading innovator in medical device technologies, announced today the successful acquisition of Mitotyping Technologies LLC, a prominent DNA forensic company specializing in advanced mitochondrial DNA analysis. This strategic move reflects Actuated Medical's commitment to diversification and growth, expanding its capabilities into the field of forensic science.

Mitotyping Technologies LLC has established itself as a trailblazer in the DNA forensic industry, providing cutting-edge solutions for mitochondrial DNA analysis for over 24 years. The acquisition aligns with Actuated Medical's vision to explore new avenues of innovation and leverage its expertise in precision engineering for applications beyond the medical field.

"We are excited to welcome Mitotyping Technologies into the Actuated Medical family," said Maureen L. Mulvihill, CEO and Founder of Actuated Medical. "This strategic acquisition not only strengthens our portfolio but also positions us at the forefront of forensic mitochondrial DNA analysis. Mitotyping Technologies has a stellar reputation for delivering high-quality results, and we look forward to integrating their expertise into our broader mission of advancing science and technology."

Mitotyping Technologies is known for its team of highly skilled scientists and exceptional success rate when working with minute, aged, and highly degraded samples. Using a unique, customized casework approach, Mitotyping Technologies has been instrumental in numerous forensic investigations.  This acquisition enables Actuated Medical to leverage Mitotyping Technologies' extensive experience and established relationships within the forensic community.

More on The PennZone
  • $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
  • Germantown Fashion & Arts Festival 2025 Draws Thousands, Celebrates Creativity in Historic Philly
  • The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
  • Casting Pro Darya Balyura Named Judge for 2025 Meals 4 Monologues Virtual Showcase

"We are thrilled to join forces with Actuated Medical, a company known for its commitment to excellence and innovation," said Gloria Dimick, Technical Leader and Forensic Examiner at Mitotyping Technologies. "Together, we believe we can push the boundaries of forensic mitochondrial DNA analysis, driving advancements that will have a positive impact on the field and contribute to the resolution of complex cases."

The integration of Mitotyping Technologies into Actuated Medical's portfolio enhances the company's ability to address the growing demand for advanced forensic DNA solutions. The combined resources, knowledge, and technologies will empower Actuated Medical to make significant contributions to the field of forensic science.

About Actuated Medical:

Actuated Medical is a medical device product innovator with an impressive portfolio boasting six FDA 510(k) clearances, over 41 US and International patents, and three products already making waves in early sales. Their unwavering focus on neuroscience, gastrointestinal, critical care, and pediatrics is reshaping the landscape of medical technology. Operating from a cutting-edge 20,000sq.ft. facility in central Pennsylvania, their ISO 13485 and WOSB certifications underscore their commitment to quality. Honored with two SBA Tibbets Awards for SBIR commercialization excellence and the 2020 Life Sciences PA CEO of the Year award, Actuated's remarkable journey includes a pivotal role in addressing the PPE shortage during the COVID crisis.

More on The PennZone
  • Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
  • New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
  • The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
  • Digital Watchdog Launches New myDW Cloud Services
  • Stan Fitzgerald Appointed Acting Press Secretary for Veterans for America First VFAF Georgia State Chapter

About Mitotyping Technologies LLC:

Mitotyping Technologies, based in the vibrant State College area, shattered the myth surrounding the legendary Wild Bill Longley with an exuberant triumph. While Texas folklore hinted at his elusive escape from the hangman's noose three times, Mitotyping Technologies definitively debunked the tale, proving his identity through forensic Mitochondrial DNA analysis. As a global leader in this field for over 20 years, their accredited DNA forensic laboratory has been instrumental in active criminal cases, post-conviction exonerations, cold cases, maternal relatedness, and missing persons investigations. Their unparalleled expertise extends to achieving superior recovery rates for mitochondrial DNA even in the most challenging samples. Mitotyping Technologies doesn't just solve cases; they redefine what's possible in forensic science with unmatched enthusiasm and dedication.

For media inquiries, please contact: Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

actuatedmedical.com

Mitotyping.com

actuatedneuroscience.com

TubeClear.com

Contact
Actuated Medical
***@actuatedmedical.com


Source: Actuated Medical, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
  • Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS)
  • Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
  • Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
  • $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
  • $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
  • #ChipInChipAway at Hunger Taking Place on July 10th, 2025
  • Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
  • Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
  • Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
  • Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
  • INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
  • AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
  • The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
  • $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
  • Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
  • BeyondTrucks CEO Wins Gold Stevie® Award for Best Entrepreneur in Transportation
  • Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
  • Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts

Popular on PennZone

  • BREAKING CONSUMER ALERT: Carvana's "Certified" Luxury SUV Buyer Exposes Legal & Mechanical Trauma 'Presses' Charges of Duress, Deception, and Delay
  • Imagen Golf Announces New Partnership with The Hurricane Golf Tour
  • INVESTIGATION ALERT: Berger Montague PC Investigates Coinbase Global, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NASDAQ: COIN)
  • Let's Talk Series: At the Crossroads: Immigration Today
  • Behavioral Health Advocates to Hold Joint Capitol Hill Press Conference on June 11
  • LIB Continuous Innovation: Custom Rain Test Chambers & IP Labs
  • Innovative EDM Music Project, "Terms of War," Depicts an A.I. Takeover of Earth
  • New Bethany Acquires Former Diocesan Headquarters to Expand Services
  • Kemeny, Ramp & Renaud Expands Legal Team with Attorney Baruch Kraut
  • Continued Streak of Recognitions with Multiple Chambers and Partners Rankings

Similar on PennZone

  • New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
  • Digital Watchdog Launches New myDW Cloud Services
  • Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
  • Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
  • $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
  • Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
  • Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
  • Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us